Identification of 5-hydroxytryptamine receptor gene polymorphisms modulating hyperprolactinaemia in antipsychotic drug-treated patients with schizophrenia; The World Journal of Biological Psychiatry; Vol. 18, iss. 3
| Parent link: | The World Journal of Biological Psychiatry Vol. 18, iss. 3.— 2016.— [P. 239-246] |
|---|---|
| Corporate Author: | Национальный исследовательский Томский политехнический университет (ТПУ) Институт неразрушающего контроля (ИНК) Кафедра экологии и безопасности жизнедеятельности (ЭБЖ) |
| Other Authors: | Ivanova S. A. Svetlana Aleksandrovna, Osmanova D. Z. Diana, Freydin M. V., Fedorenko O. Yu. Olga Yurievna, Boyko A. S. Anastasiya Sergeevna, Pozhidaev I. V. Ivan, Semke A. V. Arkady Valentinovich, Bokhan N. A. Nikolay Aleksandrovich, Agarkov A. A. Aleksey Aleksandrovich, Vilffert B. Bob, Loonen A. J. M. Anton |
| Summary: | Title screen Objectives: Hyperprolactinaemia (HPRL) is a classical side effect of antipsychotic drugs primarily attributed to blockade of dopamine D2 subtype receptors in the pituitary gland. Although dopamine is considered the primary factor inhibiting prolactin release, the activity of prolactin-producing lactotrophs is also regulated by the secretagogues thyrotrophin releasing hormone, vasoactive intestinal polypeptide and serotonin (5-hydroxytryptamine; 5-HT). Methods: We describe the association between HPRL and a set of 29 SNPs from 5-HT receptor genes HTR1A, HTR1B, HTR2A, HTR2C, HTR3A, HTR3B and HTR6 in a population of 446 Caucasians (221 males/225 females) with a clinical diagnosis of schizophrenia (according to ICD-10: F20) who were treated with classical and/or atypical antipsychotic drugs. Results: None of the studied autosomal markers were found to be associated with HPRL. However, a significant association was established between various HTR2C polymorphisms and HPRL. Conclusions: This study revealed an association between HPRL and X-chromosome haplotypes comprised of the rs569959 and rs17326429 polymorphisms. Режим доступа: по договору с организацией-держателем ресурса |
| Language: | English |
| Published: |
2016
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/15622975.2016.1224926 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=654150 |
Similar Items
Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia; Physiology and Pharmacology; Vol. 21, iss. 1
Published: (2017)
Published: (2017)
Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia; The Application of Clinical Genetics; Vol. 13
Published: (2020)
Published: (2020)
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome; Frontiers in Psychiatry; Vol. 10
Published: (2019)
Published: (2019)
Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia; Human Psychopharmacology: Clinical and Experimental; Vol. 35, iss. 4
Published: (2020)
Published: (2020)
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Published: (2018)
Published: (2018)
NMDA glutamate receptor polymorphisms modulate antipsychotic-induced hyperprolactinemia in schizophrenia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 143
Published: (2025)
Published: (2025)
Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia; British Journal of Clinical Pharmacology; Vol. 86, iss. 9
Published: (2020)
Published: (2020)
Genetic polymorphisms of PIP5K2A and course of schizophrenia; BMC Medical Genetics; Vol. 21
Published: (2020)
Published: (2020)
Apolipoprotein serum levels related to metabolic syndrome in patients with schizophrenia; Heliyon; Vol. 5, iss. 7
Published: (2019)
Published: (2019)
No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic‐induced tardive dyskinesia; Human Psychopharmacology: Clinical and Experimental; Vol. 34, iss. 1
Published: (2019)
Published: (2019)
Prolactin gene polymorphism (- 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics; Schizophrenia Research; Vol. 182
Published: (2017)
Published: (2017)
A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia; Progress in Neuro-Psychopharmacology and Biological Psychiatry; Vol. 105
Published: (2021)
Published: (2021)
Glutamate Concentration in the Serum of Patients with Schizophrenia; Procedia Chemistry; Vol. 10 : Chemistry and Chemical Engineering in XXI century
Published: (2014)
Published: (2014)
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia; Frontiers in Molecular Neuroscience; Vol. 13
Published: (2020)
Published: (2020)
Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression; Frontiers in Pharmacology; Vol. 10
Published: (2019)
Published: (2019)
A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia; BMC Medical Genetics; Vol. 20
Published: (2019)
Published: (2019)
Новый взгляд на генетику нейрокогнитивного дефицита при шизофрении; Журнал неврологии и психиатрии им. C. C. Корсакова; Т. 120, № 8
by: Федоренко О. Ю. Ольга Юрьевна
Published: (2020)
by: Федоренко О. Ю. Ольга Юрьевна
Published: (2020)
Neurobiological mechanisms associated with antipsychotic drug-induced dystonia; Journal of Psychopharmacology; Vol. 35, iss. 1
by: Loonen A. J. M. Anton
Published: (2021)
by: Loonen A. J. M. Anton
Published: (2021)
Association of PIP4K2A Polymorphisms with Alcohol Use Disorder; Genes; Vol. 12, iss. 10
Published: (2021)
Published: (2021)
A distinct serum protein pattern in patients with paranoid schizophrenia; Physiology and Pharmacology; Vol. 21, iss. 4
Published: (2017)
Published: (2017)
Salts of barbituric and 2-thiobarbituric acids with imidazole: polymorphism, supramolecular structure, thermal stability and water solubility; New Journal of Chemistry; Vol. 47, iss. 47
Published: (2023)
Published: (2023)
Study of OH- Radicals in Human Serum Blood of Healthy Individuals and Those with Pathological Schizophrenia; International journal of molecular sciences; Vol. 12, iss. 1
Published: (2011)
Published: (2011)
Circuits Regulating Pleasure and Happiness in Schizophrenia: The Neurobiological Mechanism of Delusions: Chap. 6; Schizophrenia Treatment - The New Facets
by: Loonen A. J. M. Anton
Published: (2016)
by: Loonen A. J. M. Anton
Published: (2016)
Experimental Simulation of LDPE Structure Polymorphism Occurrence Reasons; Journal of Chemistry and Chemical Engineering; Vol. 2, № 1
Published: (2015)
Published: (2015)
Likelihood of mechanistic roles for dopaminergic, serotonergic and glutamatergic receptors in tardive dyskinesia: A comparison of genetic variants in two independent patient populations; SAGE Open Medicine; Vol. 4
Published: (2016)
Published: (2016)
Cytotoxic, Genotoxic, and Polymorphism Effects on Vanilla planifolia Jacks ex Andrews after Long-Term Exposure to Argovit® Silver Nanoparticles; Nanomaterials; Vol. 8, iss. 10
Published: (2018)
Published: (2018)
Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium; Molecular Psychiatry; Vol. 24, iss. 8
Published: (2019)
Published: (2019)
Dried blood spot analysis for therapeutic drug monitoring of Clozapine; The Journal of Clinical Psychiatry; Vol. 78, iss. 9
Published: (2017)
Published: (2017)
Serum Glutathione in Patients with Schizophrenia in Dynamics of Antipsychotic Therapy; Bulletin of Experimental Biology and Medicine; Vol. 160, iss. 2
Published: (2016)
Published: (2016)
Хрестоматия по патопсихологии: учебное пособие
Published: (Москва, Изд-во МГУ, 1981)
Published: (Москва, Изд-во МГУ, 1981)
Soteria im Gesprach: Uber eine alternative Schizophreniebehandlung
by: Aebi E. Elisabeth
Published: (Bonn, Psychiatrie-Verlag, 1996)
by: Aebi E. Elisabeth
Published: (Bonn, Psychiatrie-Verlag, 1996)
Полиморфизм генов CYP1A2, CYP2D6 у больных шизофренией с лекарственно-индуцированными нейролептическими побочными эффектами; Бюллетень экспериментальной биологии и медицины; Т. 160, № 11
Published: (2015)
Published: (2015)
Карбонаты кальция в холелитах; Известия Томского политехнического университета [Известия ТПУ]; Т. 326, № 1 : Ресурсы планеты
by: Машина Е. В. Екатерина Валерьевна
Published: (2015)
by: Машина Е. В. Екатерина Валерьевна
Published: (2015)
Ассоциация полиморфизмов гена СОМТ с болезнью Паркинсона; Бюллетень сибирской медицины; Т. 16, № 3
Published: (2017)
Published: (2017)
An association of AKT1 gene polymorphism with antidepressant treatment response; The World Journal of Biological Psychiatry; Vol. 17, iss. 3
Published: (2016)
Published: (2016)
Исследование ассоциаций полиморфных вариантов генов системы цитохромов Р-450 и гена белка множественной лекарственной устойчивости с развитием лекарственно-индуцированной гиперпролактинемии при шизофрении; Перспективы развития фундаментальных наук; Т. 4 : Биология и фундаментальная медицина
by: Пожидаев И. В.
Published: (2017)
by: Пожидаев И. В.
Published: (2017)
Психотерапевтическая динамика в аналитической группе
by: Мучник М. М. Марина Моисеевна
Published: (Томск, Раско, 2001)
by: Мучник М. М. Марина Моисеевна
Published: (Томск, Раско, 2001)
Глутатион в сыворотке крови больных шизофренией в динамике антипсихотической терапии; Бюллетень экспериментальной биологии и медицины; Т. 160, № 8
Published: (2015)
Published: (2015)
Антитела к нативной и денатурированной ДНК в сыворотке крови больных шизофренией в зависимости от клинических особенностей заболевания; Экспериментально-теоретические вопросы; Т. 116, № 4
Published: (2016)
Published: (2016)
Джон Нэш - ученый-математик шизофреник и Нобелевский лауреат; Прогрессивные технологии и экономика в машиностроении
by: Осипова Л. С.
Published: (2013)
by: Осипова Л. С.
Published: (2013)
Similar Items
-
Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia; Physiology and Pharmacology; Vol. 21, iss. 1
Published: (2017) -
Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia; The Application of Clinical Genetics; Vol. 13
Published: (2020) -
Changes in Body Fat and Related Biochemical Parameters Associated With Atypical Antipsychotic Drug Treatment in Schizophrenia Patients With or Without Metabolic Syndrome; Frontiers in Psychiatry; Vol. 10
Published: (2019) -
Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia; Human Psychopharmacology: Clinical and Experimental; Vol. 35, iss. 4
Published: (2020) -
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors; The World Journal of Biological Psychiatry; Latest Articles
Published: (2018)